# A Retrospective Study to Evaluate the Safety and Efficacy of a Nucleoside-Sparing Regimen of Darunavir, Ritonavir, and Dolutegravir

> **NCT03198884** · — · COMPLETED · sponsor: **Southern Illinois Healthcare Foundation** · enrollment: 20 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** Darunavir 800 MG, Norvir 100 MG, Dolutegravir 50 MG

## Key facts

- **NCT ID:** NCT03198884
- **Lead sponsor:** Southern Illinois Healthcare Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2018-04-18
- **Final completion:** 2018-05-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-09-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03198884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03198884, "A Retrospective Study to Evaluate the Safety and Efficacy of a Nucleoside-Sparing Regimen of Darunavir, Ritonavir, and Dolutegravir". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03198884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*